OUTSOURCED PHARMA CAPACITY UPDATE SMALL MOLECULE VIDEOS
Upperton Pharma Solutions Capacity Update January 2025: Small Molecule
Gain insight into the capabilities of our award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites integrated with cutting-edge R&D and QC laboratories.
Douglas CDMO Capacity Update January 2025: Small Molecule
By leveraging our extensive experience, flexible capabilities, and client-focused approach, we help our partners accelerate time-to-market and achieve successful outcomes for their therapies.
Alcami Capacity Update January 2025: Small Molecule
With cutting-edge capabilities and client-focused solutions, Alcami supports your drug development journey from concept to commercialization, helping you bring transformative therapies to patients with speed and quality.
Ajinomoto Bio-Pharma Services Capacity Update January 2025: Small Molecule
Discover how our cutting-edge development laboratories, advanced flow chemistry units, and expanded manufacturing capacity are designed to address your most complex challenges and fulfill all your production needs.
SK pharmteco Capacity Update October 2024: Small Molecule
Witness how our 80 years of industry experience and a global capacity of ~1,000 m³ can provide scalable, high-quality solutions to support your small molecule programs.
Singota Solutions Capacity Update October 2024: Small Molecule
With advanced infrastructure and a comprehensive approach, see why we're well-positioned to support the development of stable, effective, and safe injectable products for advanced therapeutics.
PCI Pharma Capacity Update October 2024: Small Molecule
Discover how our recent investments have expanded our capacity for developing, manufacturing, and packaging highly potent drug products, leveraging over 35 years of expertise.
Lonza Capacity Update October 2024: Small Molecule
See how our AI-enabled Route Scouting Service simplifies the complexity of small molecule APIs, optimizing synthetic routes and accelerating clinical readiness.
Curia Capacity Update October 2024: Small Molecule
Use our services and solutions to advance small molecule development — from initial design and optimization to full-scale manufacturing and comprehensive analytical support.
Alcami Capacity Update October 2024: Small Molecule
Advance your pharmaceuticals and biologics from development to delivery with our services in oral solid dose development, clinical manufacturing, and commercial packaging solutions.
AbbVie Capacity Update October 2024: Small Molecule
Watch this overview of our extensive capabilities, including a deep dive into our HPAPI and API services and the available capacity at our Campoverdi, Italy facility for your next project.
Douglas CDMO Capacity Update July 2024: Small Molecule Finished Dosage Form
We specialize in high-potency softgels and liquids and have deep experience producing prescription drugs for classifications including oncology, dermatology, the central nervous system and immunity.
Alcami Capacity Update July 2024: Small Molecule Finished Dosage Form
Alcami boasts a state-of-the-art OSD development suite that includes manufacturing equipment, non-GMP analytical testing lab, stability chambers, and small scale blistering equipment.
AustinPx Capacity Update July 2024: Small Molecule Finished Dosage Form
Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges.
Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development
Learn about Curia’s industry-leading practices in critical disciplines such as high-potency compounds, commercialization of products with our customers, and our growing expertise in chromatography.
AbbVie Capacity Update July 2024: Small Molecule APl And HPAPI Development
Review a detailed examination of our HPAPI & API capabilities, with a particular focus on our Campoverdi, Italy facility which currently has capacity available for near-term projects.
MilliporeSigma Capacity Update May 2024: Small Molecule APl and HPAPI Development
Our small molecule API CDMO team has the expertise, experience, and specialized facilities to make our customers' small molecule API projects a success.
Capacity Update May 2024: Small Molecule APl And HPAPI Development
With 37 cGMP mills of different sizes and types, and dedicated areas for steroids, HPAPIs, and even cryogenic milling, our Monteggio site is well-equipped to support a wide range of customer projects.
Ajinomoto Bio-Pharma Services Capacity Update May 2024: Small Molecule APl and HPAPI Development
Our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late stage projects.
Adare Pharma Solutions Capacity Update May 2024: Small Molecule APl and HPAPI Development
An outsourcing partner with services from the earliest phases of development and formulation to manufacturing and packaging is critical for advancing your product to market with reduced cost and time.
Don't miss our next installment!
These conferences are ideal for professionals who have the authority to choose and manage CDMO relationships and need to secure capacity for their development or commercial programs.
How can we help?
Are you a supplier looking to present at our next event?